HOME Top Market Reports Clinical Trial Imaging Market by Product & Services (Software), Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-Ray), End User (Pharmaceutical Companies, Biotechnology Companies, CROs, Medical Device Manufacturers) - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services (Software), Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-Ray), End User (Pharmaceutical Companies, Biotechnology Companies, CROs, Medical Device Manufacturers) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: December 2016
Report Code: MD 4818

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global clinical trial imaging market is projected to reach USD 1069.7 Million by 2021 from USD 773.4 Million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending by growing pharmaceutical and biotechnology industries is attributed to the growth of the market.

In this report, the global market is broadly segmented by product and service, modality, end user, and region. The market, on the basis of product and service, is segmented into software and services. The service segment is expected to account for the largest share of the market in 2016. The large share of this segment can primarily be attributed to high cost of the imaging equipment, which is leading to increased outsourcing of imaging clinical trial by pharmaceutical, biotechnology, and medical device manufacturers to service providers.

Geographically, the clinical trial imaging market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to command the largest share of the global market in 2016. This market is primarily driven by large R&D spending, growing number of pharmaceutical & biotechnology companies, and increasing number of CROs. Asia is expected to grow at the highest CAGR in the forecast period. The growth in the Asian market is driven by the growth in pharmaceutical & biotechnology industries and increase in R&D spending in the region.

This research study involved the extensive usage of both primary and secondary data sources as well as various factors affecting the industry, including the regulatory landscape; competitive scenario; historic data; current trends in the market; technological innovations and upcoming technologies; and market drivers, restraints, opportunities, and challenges. The clinical trial imaging market is dominated by established players such as BioClinica, Inc. (U.S.), PAREXEL International Corporation (U.S.), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (U.S.), IXICO, PLC (U.K.).

Stakeholders

  • Medical Device Industries
  • Academic and Government Research Institutes
  • Diagnostic Centers
  • Market Research & Consulting Firms
  • Clinical Trial Imaging Manufacturers, Vendors, and Distributors
  • Pharmaceutical and Biotechnology Companies and Contract Research Organizations (CROs)

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

Some companies in this market are privately owned and their revenues are not available in the public domain. Hence, revenues for those companies are not included in the report

Company developments not reported in public domain are not included in the report

Particular

Scope

Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Asia-Pacific
  • RoW

Historical Years

2014

Base Year

2015

Estimated Year

2016-e

Forecast Period

2016-e–2021-p

Revenue Currency

USD

Market Segmentation

This research report categorizes the clinical trial imaging market on the basis of product and service, modality, end users, and regions.

Global Clinical Trial Imaging Market, by Product and Service

  • Services
  • Software

Global Clinical Trial Imaging Market, by Modality

  • Computed Tomography
  • Magnetic Resonance Imaging
  • Positron Emission Tomography
  • Ultrasound
  • X-Ray
  • Echocardiography
  • Other Modalities (Magnetic Resonance Elastography and Dual-energy x-ray Absorptiometry)

Global Clinical Trial Imaging Market, by End User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Manufacturers
  • Contract Research Organizations
  • Academic and Government Research Institutes
  • Other End Users (Cosmetics & skin care industries)

Global Clinical Trial Imaging Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the Asian clinical trial imaging market into China, Japan, India, and Rest of Asia
  • Further breakdown of the European clinical trial imaging market into Germany, France, the U.K., and Rest of Europe

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of The Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered in The Study
    1.4 Currency
    1.5 Limitation
    1.6 Stakeholders

2 Research Methodology (Page No. - 17)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Market Rank Estimation
           2.3.1 Key Data From Secondary Sources
           2.3.2 Key Data From Primary Sources
           2.3.3 Key Industry Insights
           2.3.4 Assumptions for The Study

3 Executive Summary (Page No. - 24)

4 Premium Insights (Page No. - 27)
    4.1 Clinical Trial Imaging: Market Overview
    4.2 Clinical Trial Imaging Market, By Product & Service, 2016
    4.3 Clinical Trial Imaging Market Size, By Modality, 2016 vs 2021
    4.4 Clinical Trial Imaging Market Size, By End User, 2016 vs 2021
    4.5 Geographic Snapshot of The Clinical Trial Imaging Market
    4.6 Life Cycle Analysis, By Region

5 Market Overview (Page No. - 32)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increase in R&D Spending
                    5.2.1.2 Growth in The Pharmaceutical and Biotechnology Industries
                    5.2.1.3 Increasing Number of Cros
           5.2.2 Restraints
                    5.2.2.1 High Implementation Cost of Imaging Systems
           5.2.3 Opportunities
                    5.2.3.1 Emerging Economies
                    5.2.3.2 Development of Innovative Imaging Modalities, Contrast Agents, Molecular Probes, and Radiopharmaceuticals
           5.2.4 Challenges
                    5.2.4.1 High Cost of Clinical Trials
                    5.2.4.2 High Cost of Pet
    5.3 Recent Market Trends
           5.3.1 Rising Demand for Multimodality Imaging Technology in Clinical Trials
    5.4 Regulatory Scenario
    5.5 Clinical Trials: Global Scenario

6 Clinical Trial Imaging Market, By Product and Service (Page No. - 39)
    6.1 Introduction
    6.2 Services
           6.2.1 Operational Imaging Services
           6.2.2 Read Analysis Services
           6.2.3 System and Technical Support Services
           6.2.4 Trial Design Consulting Services
    6.3 Software

7 Clinical Trial Imaging Market, By Modality (Page No. - 48)
    7.1 Introduction
    7.2 Computed Tomography
    7.3 Magnetic Resonance Imaging
    7.4 Ultrasound
    7.5 Positron Emission Tomography
    7.6 X-Ray
    7.7 Echocardiography
    7.8 Other Modalities

8 Clinical Trial Imaging Market, By End User (Page No. - 57)
    8.1 Introduction
    8.2 Pharmaceutical Companies
    8.3 Biotechnology Companies
    8.4 Medical Device Manufacturers
    8.5 Contract Research Organizations
    8.6 Academic and Government Research Institutes
    8.7 Other End Users

9 Clinical Trial Imaging Market, By Region (Page No. - 68)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
    9.4 Asia
    9.5 Rest of The World (RoW)

10 Competitive Landscape (Page No. - 89)
     10.1 Introduction
     10.2 Strategic Overview
     10.3 Competitive Situation and Trends
     10.4 Leading Players in The Clinical Trial Imaging Market
             10.4.1 Agreements, Collaborations, and Partnerships
             10.4.2 Expansion
             10.4.3 Acquisition
             10.4.4 Product and Service Launches & Product Upgrades

11 Company Profiles (Page No. - 95)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     11.1 Introduction
     11.2 Bioclinica, Inc.
     11.3 Parexel International Corporation
     11.4 Icon PLC
     11.5 Biomedical Systems Corporation
     11.6 Biotelemetry, Inc.
     11.7 Cardiovascular Imaging Technologies, LLC
     11.8 Intrinsic Imaging LLC
     11.9 Ixico PLC
     11.10 Radiant Sage LLC
     11.11 Worldcare Clinical, LLC
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 112)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Other Developments
     12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.5 Introducing RT: Real-Time Market Intelligence
     12.6 Available Customizations
     12.7 Related Reports
     12.8 Author Details


List of Tables (77 Tables)

Table 1 Phases of Clinical Trials
Table 2 Global Scenario of Clinical Trials Till 2015
Table 3 Clinical Trial Imaging Market Size, By Product and Service, 2014–2021 (USD Million)
Table 4 Clinical Trial Imaging Services Market Size, By Type, 2014–2021 (USD Million)
Table 5 Clinical Trial Imaging Services Market Size, By Region, 2014–2021 (USD Million)
Table 6 North America: Clinical Trial Imaging Services Market Size, By Country, 2014–2021 (USD Million)
Table 7 Operational Imaging Services Market Size, By Region, 2014–2021 (USD Million)
Table 8 North America: Operational Imaging Services Market Size, By Country, 2014–2021 (USD Million)
Table 9 Read Analysis Services Market Size, By Region, 2014–2021 (USD Million)
Table 10 North America: Read Analysis Services Market Size, By Country, 2014–2021 (USD Million)
Table 11 System and Technical Support Services Market Size, By Region, 2014–2021 (USD Million)
Table 12 North America: System and Technical Support Services Market Size, By Country, 2014–2021 (USD Million)
Table 13 Trial Design Consulting Services Market Size, By Region, 2014–2021 (USD Million)
Table 14 North America: Trial Design Consulting Services Market Size, By Country, 2014–2021 (USD Million)
Table 15 Clinical Trial Imaging Software Market Size, By Region, 2014–2021 (USD Million)
Table 16 North America: Clinical Trial Imaging Software Market Size, By Country, 2014–2021 (USD Million)
Table 17 Market Size, By Modality, 2014–2021 (USD Million)
Table 18 Market Size for CT, By Region, 2014–2021 (USD Million)
Table 19 North America: Market Size for CT, By Country, 2014–2021 (USD Million)
Table 20 Market Size for Mri, By Region, 2014–2021 (USD Million)
Table 21 North America: Market Size for Mri, By Country, 2014–2021 (USD Million)
Table 22 Market Size for Ultrasound, By Region, 2014–2021 (USD Million)
Table 23 North America: Market Size for Ultrasound, By Country, 2014–2021 (USD Million)
Table 24 Market Size for Pet, By Region, 2014–2021 (USD Million)
Table 25 North America: Market Size for Pet, By Country, 2014–2021 (USD Million)
Table 26 Market Size for X-Ray, By Region, 2014–2021 (USD Million)
Table 27 North America: Market Size for X-Ray, By Country, 2014–2021 (USD Million)
Table 28 Market Size for Echocardiography, By Region, 2014–2021 (USD Million)
Table 29 North America: Market Size for Echocardiography, By Country, 2014–2021 (USD Million)
Table 30 Market Size for Other Modalities, By Region, 2014–2021 (USD Million)
Table 31 North America: Market Size for Other Modalities, By Country, 2014–2021 (USD Million)
Table 32Market Size, By End User, 2014–2021 (USD Million)
Table 33 Market Size, By Region, 2014–2021 (USD Million)
Table 34 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 35 Market Size for Pharmaceutical Companies, By Region, 2014–2021 (USD Million)
Table 36 North America: Market Size for Pharmaceutical Companies, By Country, 2014–2021 (USD Million)
Table 37 Market Size for Biotechnology Companies, By Region, 2014–2021 (USD Million)
Table 38 North America: Market Size for Biotechnology Companies, By Country, 2014–2021 (USD Million)
Table 39 Market Size for Medical Device Manufacturers, By Region, 2014–2021 (USD Million)
Table 40 North America: Market Size for Medical Device Manufacturers, By Country, 2014–2021 (USD Million)
Table 41 Market Size for Contract Research Organizations, By Region, 2014–2021 (USD Million)
Table 42 North America: Market Size for Contract Research Organizations , By Country, 2014–2021 (USD Million)
Table 43 Market Size for Academic and Government Research Institutes, By Region, 2014–2021 (USD Million)
Table 44 North America: Market Size for Academic and Government Research Institutes, By Country, 2014–2021 (USD Million)
Table 45 Market Size for Other End Users, By Region, 2014–2021 (USD Million)
Table 46 North America: Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 47 Market Size, By Region, 2014–2021 (USD Million)
Table 48 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 49 North America: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 50 North America: Clinical Trial Imaging Services Market Size, By Type, 2014-2021 (USD Million)
Table 51 North America: Market Size, By Modality, 2014–2021 (USD Million)
Table 52 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 53 U.S.: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 54 U.S.: Clinical Trial Imaging Services Market Size, By Type, 2014-2021 (USD Million)
Table 55 U.S.: Market Size, By Modality, 2014–2021 (USD Million)
Table 56 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 57 Canada: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 58 Canada: Clinical Trial Imaging Services Market Size, By Type, 2014-2021 (USD Million)
Table 59 Canada: Market Size, By Modality, 2014–2021 (USD Million)
Table 60 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 61 Europe: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 62 Europe: Clinical Trial Imaging Services Market Size, By Type, 2014-2021 (USD Million)
Table 63 Europe: Market Size, By Modality, 2014–2021 (USD Million)
Table 64 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 65 Asia: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 66 Asia: Clinical Trial Imaging Services Market Size, By Type, 2014-2021 (USD Million)
Table 67 Asia: Market Size, By Modality, 2014–2021 (USD Million)
Table 68 Asia: Market Size, By End User, 2014–2021 (USD Million)
Table 69 RoW: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 70 RoW: Clinical Trial Imaging Services Market Size, By Type, 2014-2021 (USD Million)
Table 71 RoW: Market Size, By Modality, 2014–2021 (USD Million)
Table 72 RoW: Market Size, By End User, 2014–2021 (USD Million)
Table 73 Rank of Companies in The Global Clinical Trial Imaging Market, 2015
Table 74 Agreements, Collaborations, and Partnerships, 2013–2016
Table 75 Expansions, 2013–2016
Table 76 Acquisitions, 2013–2016
Table 77 Product and Service Launches & Product Upgrades, 2013–2016


List of Figures (32 Figures)

Figure 1 Clinical Trial Imaging Market Segmentation
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Market Size, By Product & Service, 2016 vs 2021 (USD Million)
Figure 8 Market Size, By Modality, 2016 vs 2021 (USD Million)
Figure 9 Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 10 Geographic Snapshot of The Market
Figure 11 Emerging Economies Offer Significant Growth Opportunities for Players in The Market
Figure 12 Services Segment to Account for The Largest Share of The Market in 2016
Figure 13 Pet Modality Segment to Register The Highest CAGR During The Forecast Period
Figure 14 Pharmaceutical Companies to Account for The Largest Market Share in 2016
Figure 15 Asia to Register The Highest Growth Rate From 2016 to 2021
Figure 16 Asia Offers Significant Growth Opportunities in The Forecast Period
Figure 17 Increase in R&D Spending Will Drive The Growth of The Clinical Trial Imaging Market
Figure 18 Clinical Trial Imaging Services to Form The Largest Segment in 2016
Figure 19 CT Segment to Dominate The Clinical Trial Imaging Market in 2016
Figure 20 Pharmaceutical Companies to Account for The Largest Share of The Clinical Trial Imaging Market in 2016
Figure 21 Number of Biotechnology and Pharmaceutical Patents Granted in 2012, By Region
Figure 22 North America to Dominate The Clinical Trial Imaging Market During The Forecast Period
Figure 23 Clinical Trial Imaging Market in Asia Expected to Grow at The Highest Rate During The Forecast Period
Figure 24 North America: Clinical Trial Imaging Market Snapshot
Figure 25 Asia: Clinical Trial Imaging Market Snapshot
Figure 26 Agreements, Partnerships, and Collaborations is The Key Growth Strategy Adopted By Players in The Clinical Trials Imaging Market
Figure 27 Battle for Market Share: Agreements, Collaborations, and Partnerships: The Key Strategies Adopted By Players Between January 2013 and October 2016
Figure 28 Geographic Revenue Mix of The Top Three Market Players
Figure 29 Company Snapshot: Parexel International Corporation
Figure 30 Company Snapshot: Icon PLC
Figure 31 Company Snapshot: Biotelemetry, Inc.
Figure 32 Company Snapshot: Ixico PLC

The global clinical trial imaging market is projected to reach USD 1069.7 Million by 2021 from USD 773.4 Million in 2016, at a CAGR of 6.7% from 2016 to 2021.In this report, the global market is broadly segmented by product and service, modality, end user, and region.

Major factors fueling market growth are the increase in R&D spending and growth in the pharmaceutical and biotechnology industries and the increasing number of contract research organizations are the key drivers for the growth of the market. On the other hand, the high implementation cost of imaging systems is restraining the growth of this market.

On the basis of product and service, the market is segmented into service and software. The service segment is expected to account for the largest share of the market in 2016. The large share of this segment can primarily be attributed to high cost of the imaging equipment, which is leading to increased outsourcing of imaging clinical trial by pharmaceutical, biotechnology, and medical device manufacturers to service providers.

Furthermore, On the basis of modality, the clinical trial imaging market is broadly classified into CT, MRI, PET, ultrasound, ECHO, x-ray, and other modalities (such as magnetic resonance elastography (MRE) and dual-energy X-ray absorptiometry (DXA)). In 2016, the CT segment is expected to account for the largest share of the global market. The large share of this segment is attributed to the high advantages of CT in screenings for cancer (tumors), injuries, and abnormalities inside the body.

On the basis of end user, the market is categorized into pharmaceutical companies, biotechnology companies, medical device manufacturers, contract research organizations, academic and government research institutes, and other end users (cosmetics and skin care companies). Pharmaceutical companies are expected to account for the largest share of the global market in 2016. Increased R&D budgets of pharmaceutical companies is the primary growth driver for this end-user segment.

Geographically, the clinical trial imaging market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to command the largest share of the global market in 2016. This market is primarily driven by large R&D spending, growing number of pharmaceutical & biotechnology companies, and increasing number of CROs. Asia is expected to grow at the highest CAGR in the forecast period. The growth in the Asian market is driven by the growth in pharmaceutical & biotechnology industries and increase in R&D spending in the region.

The key players in the global clinical trial imaging market are BioClinica, Inc. (U.S.), Biomedical Systems (U.S.), Cardiovascular Imaging Technologies (U.S.), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (U.S.), IXICO, PLC (U.K.), PAREXEL International Corporation (U.S.), Radiant Sage, LLC (U.S.), BioTelemetric, Inc. (U.S.), and WorldCare Clinical, LLC (U.S.).

Clinical Trials Imaging Market

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Available Customizations Title

Client Consult Problem Statement : MnM’s client was a leading manufacturer of various clinical laboratory products and wanted to enter in African market and was majorly interested in knowing current scenario and understanding various opportunities present in this market. The client was looking for information related to major test types by volume, leading laboratory departments by volume, number of tests performed by leading players, potential countries, major laboratory instrument providers, competitive landscape for leading labs and end-user preferences

Solution Provided:

1. Methodology Adopted by MnM :

The study involved extensive interviews with the Primar....

1. Methodology Adopted by MnM :

The study involved extensive interviews with the Primary respondents from the demand side involving key laboratory personnel for the estimation of the Total Addressable Market (TAM) to understand the current scenario. MnM analyzed current & forecast quantitative market information for the market sizing and forecasted the growth of the Laboratory product market. For understanding the epidemiological aspect of key application areas in all the specified regions data from was gathered from the Laboratories associations and the doctors involved to understand the current trends and processes involved.

2. Actual Solution Provided:

   • Estimation of total addressable market size and forecast (for next 5 years)
   • Regional and Country-wise analysis for 18 major African countries
   • Identification of potential countries by ranking them using various socio-economic parameters
   • Analysis of contribution by public and private sector for each country
   • Analyzing various macro and micro factors impacting market growth
   • Business insights to formulate optimum strategy to grab market opportunity in potential countries

Value Delivered:

After working through the detailed market analysis and end-user market assessment by MnM, client successfully formulated its market entry strategy to in selected African countries to introduce its clinical laboratory products for major laboratories in the region.

less...
Request Customization
 more...
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo